Bleakley Financial Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
+20,318
| New | +$1.77M | 0.05% | 293 |
|
|
2025
Q1 | – | Sell |
-4,968
| Closed | -$386K | – | 641 |
|
|
2024
Q4 | $386K | Sell |
4,968
-322
| -6% | -$25K | 0.01% | 695 |
|
|
2024
Q3 | $355K | Sell |
5,290
-1,903
| -26% | -$128K | 0.01% | 709 |
|
|
2024
Q2 | $816K | Buy |
7,193
+337
| +5% | +$38.2K | 0.02% | 467 |
|
|
2024
Q1 | $951K | Buy |
6,856
+87
| +1% | +$12.1K | 0.03% | 441 |
|
|
2023
Q4 | $840K | Sell |
6,769
-8,496
| -56% | -$1.05M | 0.03% | 442 |
|
|
2023
Q3 | $1.42M | Sell |
15,265
-1,604
| -10% | -$150K | 0.05% | 320 |
|
|
2023
Q2 | $2.17M | Sell |
16,869
-1,005
| -6% | -$129K | 0.07% | 254 |
|
|
2023
Q1 | $2.08M | Sell |
17,874
-8,973
| -33% | -$1.04M | 0.07% | 246 |
|
|
2022
Q4 | $3.04M | Buy |
+26,847
| New | +$3.04M | 0.11% | 176 |
|